Martin Shkreli - Wikipedia
Martin Shkreli (/ ˈ ʃ k r ɛ l i /; born March 17, 1983) is an American investor and businessman. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals , and the former CEO of start-up software company ...
'Pharma Bro' Martin Shkreli released from prison : NPR
May 19, 2022 · In 2017 a federal jury found Shkreli, dubbed "Pharma Bro" in the media, guilty on two counts of securities fraud and one count of conspiracy to commit securities...
Supreme Court rejects appeal from ‘Pharma Bro’ Martin Shkreli
Oct 7, 2024 · The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the price of a lifesaving drug.
‘Pharma Bro’ Martin Shkreli Still Banned For Life From ... - Forbes
Jan 23, 2024 · Martin Shkreli, the notorious former CEO of Turing Pharmaceuticals and convicted securities fraudster, will still be banned from working in the pharmaceutical industry after a federal...
Martin Shkreli is ordered to return $64M, barred from drug industry - NPR
Jan 14, 2022 · Martin Shkreli, who is serving a seven-year prison sentence for fraud, must return profits he and his former company reaped from raising the price of a lifesaving drug, a federal judge...
Martin Shkreli lifetime drug ban upheld by appeals court
Jan 23, 2024 · A federal appeals court Tuesday upheld a lifetime ban on "pharma bro" Martin Shkreli from working in the pharmaceuticals industry as well as an order to pay up to $64.6 …
Eastern District of New York | Martin Shkreli Sentenced to Seven …
Mar 9, 2018 · Shkreli, a Former Hedge Fund Manager and CEO of a Biopharmaceutical Company, Defrauded Investors and Engaged in Stock Fraud Scheme Involving Publicly Traded Retrophin Inc.
Statement on Second Circuit Order Upholding “Pharma Bro” Martin Shkreli …
Jan 23, 2024 · Today, the United States Court of Appeals for the Second Circuit affirmed a district court ruling which ordered “Pharma Bro” Martin Shkreli to face a lifetime ban from participating in the pharmaceutical industry and found Shkreli liable for $64.6 million in disgorgement for his role in orchestrating an illegal anticompetitive scheme.
Martin Shkreli's lifetime drug industry ban upheld | Reuters
Jan 23, 2024 · Martin Shkreli, known for once hiking the price of a life-saving drug more than 4,000%, cannot return to the pharmaceutical industry after a federal appeals court on Tuesday upheld his lifetime...
Martin Shkreli Barred From Drug Industry and Must Repay $64.6 …
Jan 14, 2022 · Martin Shkreli, the former pharmaceutical executive best known for unapologetically hiking the price of a lifesaving medication, must pay $64.6 million and will be barred for life from the drug...